ViewRay

ViewRay Revenue

The The revenue of ViewRay (VRAYQ) as of Oct 18, 2026 is 102.21 M USD. In the previous year, The revenue was 70.12 M USD — a change of 45.76% (higher).

Revenue

102.21 MUSD

YoY

45.76%

Last updated:

In 2022, ViewRay's sales reached 102.21 M USD, a 45.76% difference from the 70.12 M USD sales recorded in the previous year.

Revenue has compounded at 49.3% per year over the past 10 years to 102.21 M USD.

The ViewRay Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
Date
Revenue
Jan 1, 2019
87.78 M USD
Jan 1, 2020
57.02 M USD
Jan 1, 2021
70.12 M USD
Jan 1, 2022
102.21 M USD
Jan 1, 2023 (e)
0.00 USD
Jan 1, 2024 (e)
0.00 USD
Jan 1, 2025 (e)
121.78 M USD
Jan 1, 2026 (e)
306.40 M USD
The ViewRay Revenue history
YEARRevenueYoY
est306.40 MUSD+151.61%
est121.78 MUSD—
est0.00USD—
est0.00USD-100.00%
102.21 MUSD+45.76%
70.12 MUSD+22.98%
57.02 MUSD-35.05%
87.78 MUSD+8.42%
80.96 MUSD+137.83%
34.04 MUSD+53.09%
22.24 MUSD+114.02%
10.39 MUSD+62.34%
6.40 MUSD+102.60%
3.16 MUSD+70.39%
1.85 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ViewRay Revenue

ViewRay Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
87.78 M USD
-120.80 M USD
-120.20 M USD
Jan 1, 2020
57.02 M USD
-105.39 M USD
-107.91 M USD
Jan 1, 2021
70.12 M USD
-105.82 M USD
-110.05 M USD
Jan 1, 2022
102.21 M USD
-103.96 M USD
-107.33 M USD
Jan 1, 2023 (e)
0.00 USD
-100.12 M USD
0.00 USD
Jan 1, 2024 (e)
0.00 USD
-86.42 M USD
0.00 USD
Jan 1, 2025 (e)
121.78 M USD
-118.11 M USD
-53.20 M USD
Jan 1, 2026 (e)
306.40 M USD
-297.17 M USD
-11.00 M USD

ViewRay Margins

ViewRay stock margins

The ViewRay margin analysis displays the gross margin, EBIT margin, as well as the profit margin of ViewRay. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for ViewRay.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
-6.24 %
-137.61 %
-136.93 %
Jan 1, 2020
-7.12 %
-184.84 %
-189.26 %
Jan 1, 2021
0.48 %
-150.91 %
-156.94 %
Jan 1, 2022
9.83 %
-101.72 %
-105.01 %
Jan 1, 2023 (e)
9.83 %
- %
0.00 %
Jan 1, 2024 (e)
9.83 %
- %
0.00 %
Jan 1, 2025 (e)
9.83 %
-96.99 %
-43.69 %
Jan 1, 2026 (e)
9.83 %
-96.99 %
-3.59 %

ViewRay Stock analysis

What does ViewRay do? ViewRay Inc. is an American medical technology company based in Cleveland, Ohio. It was founded in 2004 by Ivor Jankovic and specializes in the manufacturing of radiation therapy devices. The history of ViewRay begins with the idea of developing innovative technology to treat cancer patients more effectively and gently. In 2005, the company entered into an agreement with the Cleveland Clinic Lerner Research Institute to conduct research on a novel magnetic resonance-guided radiation therapy machine. The research project was led by James F. Dempsey, Chair of the Department of Radiation Oncology at the Cleveland Clinic. In 2009, the first magnetic resonance-guided radiation therapy system was delivered and implemented at the Cleveland Clinic. ViewRay's business model is based on the development and manufacturing of innovative medical devices aimed at making the treatment of cancer patients more effective and gentle. The company focuses on combining magnetic resonance imaging (MRI) and radiation therapy to ensure more precise and safer treatment. ViewRay offers various products, including the MRIdian-Linac system, an advanced radiation therapy device that utilizes MRI technology to provide real-time images of the tumor during radiation. This allows for precise targeting of the tumor while sparing the surrounding tissue. The system also offers the ability to sync radiation therapy with the patient's breathing cycle, further improving the accuracy and effectiveness of the treatment. In addition to the MRIdian-Linac system, ViewRay also offers the MRIdian-MRI system, which is solely dedicated to imaging. The MRIdian-MRI is a diagnostic instrument that allows for better visualization of tissue and tumor studies. The system uses the same MRI technology as the MRIdian-Linac to generate radiation-free images. ViewRay has also specialized in the development of software tools that assist doctors in better planning and monitoring radiation therapy. This includes the RayCare Oncology Information System, which provides a comprehensive workflow and management platform, as well as the RayStation Treatment Planning Software, which enables more precise radiation therapy planning. In terms of market reach, ViewRay has a global presence. The company has a strong presence in North America, Europe, and Asia, and works closely with leading research institutes and hospitals to evaluate and improve the effectiveness and efficiency of its technologies. Overall, ViewRay has developed an innovative and unique portfolio of products and solutions that improve radiation therapy and increase accuracy and safety for patients and doctors. The company is a leader in the development of MRI-guided radiation therapy systems and is expected to continue playing a significant role in the medical technology industry in the future. ViewRay is one of the most popular companies on Eulerpool.

Revenue Details

Understanding ViewRay's Sales Figures

The sales figures of ViewRay originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing ViewRay’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize ViewRay's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in ViewRay’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about ViewRay stock

The revenue of ViewRay is 102.21 M USD in 2022.

The revenue of ViewRay changed from 70.12 M USD to 102.21 M USD, representing a 45.76% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The revenue ViewRay since 2006 – with annual values, charts, and detailed analysis.

Revenue is the total value of all goods sold in a period. It is calculated by multiplying the quantity of each product sold by its selling price. Revenue does not include any costs (material costs, personnel costs, etc.), whereas net proceeds only deduct revenue reductions associated with the sale (discounts, etc.).

The revenue's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The revenue's ViewRay historically and in real time.

The revenue in assessing a stock

Revenue is an important financial measure used in the valuation of stocks. It is a measure of a company's economic activity and can serve as an indicator of the company's success. Revenue is considered one of the most important factors in stock valuation. In addition, revenue can also be used to calculate other financial measures such as earnings per share and price-earnings ratio.

History and utilization of revenue

Revenue has long been considered one of the most important financial indicators. It was used in the 19th century as one of the first financial indicators to measure a company's economic activity. Since then, revenue has been regularly used to evaluate companies.

Revenue is usually calculated as a percentage of the company's equity. It can also be used to determine the overall profitability of a company. There are many different types of revenue that can be used to measure a company's economic activity, such as gross revenue, net revenue, and revenue from international business.

The revenue can also be used to evaluate stocks. For example, the revenue of a company can be used to evaluate the success of the company. If a company has high revenue, it means that it is a profitable company because it has high demand for its products or services.

Calculation and Application of Revenue

In order to calculate a company's revenue, the company's income must be deducted from its expenses. The income can come from various sources, such as sales, licensing fees, services, etc. The expenses can include costs for production, procurement, inventory, sales, and administration.

The revenue can then be used to calculate various financial ratios. For example, the revenue can be used to calculate the price-earnings ratio (P/E ratio) of a company. This is a measure of a company's profitability, calculated by taking the ratio of the stock price to earnings per share.

Revenue can also be used to calculate earnings per share (EPS) of a company. This is a measure of a company's profit per share. EPS is calculated by dividing earnings by the number of shares issued.

Use of revenue by investors

Investors use revenue to evaluate stocks, as revenue is an indicator of a company's success. For example, an investor can compare a company's revenue to see how successful it is. An investor can also use a company's revenue to calculate its price-to-earnings ratio and earnings per share.

An example: An investor looks at a company that has a revenue of 25 million euros. He compares this revenue to that of the competitor, which has a revenue of 35 million euros. The investor can then see that the company with 25 million euros in revenue is less successful than the company with 35 million euros in revenue.

Advantages and Disadvantages of Revenue.

Revenue is a very useful tool for valuing stocks as it measures a company's economic activity. Revenue can also be used to calculate other financial ratios such as the price-earnings ratio and earnings per share.

However, one disadvantage is that revenue alone is not a meaningful indicator of a company's success. It is important to consider revenue in comparison to other financial metrics such as earnings per share and price-to-earnings ratio to get a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — ViewRay

All Key Metrics — ViewRay